youtube_live
Q3 2026 earnings • released • EPS beat +11.92% • Revenue beat +2.33%
See resultschevron_right
BAX:NYSE
Baxter International Inc
$24.22
arrow_upward
+5.51%(+1.26) 1D
$24.22
0.00% (0.00)
todayPre-market
Closed: Nov 2, 4:00:05 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BAX...
Open
$23.34
High
$24.25
Low
$23.26
Mkt. cap
12.53B
Avg. vol.
7.11M
Volume
922.00
Dividend
0.17%
Quarterly dividend
$0.01
Ex-dividend date
Aug 28, 2026
52-wk high
$30.00
52-wk low
$15.73
EPS
-$1.42
Beta
0.66
Shares outstanding
517.35M
No. of employees
38K
Open
$23.34
High
$24.25
Low
$23.26
Mkt. cap
12.53B
Avg. vol.
7.11M
Volume
922.00
Dividend
0.17%
Quarterly dividend
$0.01
Ex-dividend date
Aug 28, 2026
52-wk high
$30.00
52-wk low
$15.73
EPS
-$1.42
Beta
0.66
Shares outstanding
517.35M
No. of employees
38K
News stories
From web sources and news partners
News Corp
·
13 hours ago
Baxter International Inc. stock outperforms competitors on strong trading day
Yahoo Finance
·
3 days ago
Baxter International Inc. Q3 2026 Earnings Call Summary
Profile
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
About Baxter International Inc
CEOAndrew Hider
Employees37.5K
Founded1931
HeadquartersDeerfield, Illinois, United States
SectorMedical device
Websitebaxter.com
Analyst ratings
Based on 7 analysts giving stock ratings to BAX in the past 3 months
Hold
Buy
0
Hold
6
Sell
1
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BAX in the last 3 months.
Highest
Current $24.22
$28.00 (+15.61%)
Average
$25.00 (+3.22%)
Lowest
$20.00 (-17.42%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Robbie Marcus J.P. Morgan | Hold | Maintained | $25.00 | +3.2% | 10/30/2026 |
Rick Wise Stifel Nicolaus | Hold | Maintained | $25.00 | +3.2% | 10/30/2026 |
Christopher Pasquale Barclays | Sell | Maintained | $20.00 | -17.4% | 10/30/2026 |
Larry Biegelsen Wells Fargo | Hold | Maintained | $25.00 | +3.2% | 10/30/2026 |
Matthew Taylor Jefferies | Hold | Maintained | $25.00 | +3.2% | 10/29/2026 |
Matt Miksic Barclays | Sell | Maintained | $20.00 | -17.4% | 10/07/2026 |
Joanne Wuensch Citi | Hold | Maintained | $27.00 | +11.5% | 10/05/2026 |
Travis Steed Bank of America Securities | Hold | Maintained | $28.00 | +15.6% | 08/11/2026 |
Pito Chickering Deutsche Bank | Hold | Maintained | $27.00 | +11.5% | 07/31/2026 |
Josh Jennings TD Cowen | Hold | Maintained | $29.00 | +19.7% | 07/31/2026 |
Unknown Analyst Wells Fargo | Hold | Reiterated | $23.00 | -5% | 07/31/2026 |
Danielle Antalffy UBS | Hold | Reiterated | $25.00 | +3.2% | 07/28/2026 |
Patrick Wood UBS | Hold | Reiterated | $25.00 | +3.2% | 07/28/2026 |
David Roman Goldman Sachs | Hold | Reiterated | $21.00 | -13.3% | 07/15/2026 |
Vijay Kumar Evercore ISI | Buy | Maintained | $24.00 | -0.9% | 07/06/2026 |
Steven Silver Argus Research | Hold | Maintained | - | - | 05/08/2026 |
Last report
Oct 29, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.58 / $0.52
+11.92%beat
arrow_upward
Revenue / Est. (USD)
2.98B / 2.91B
+2.33%beat
arrow_upward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 2.97B | 2.70B | 2.96B | 2.98B |
Cost of goods sold | 2.01B | 1.80B | 1.91B | 1.93B |
Cost of revenue | 2.01B | 1.80B | 1.91B | 1.93B |
Research and development expenses | 116.00M | 124.00M | 125.00M | 118.00M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 675.00M | 658.00M | 693.00M | 680.00M |
Operating expense | 741.00M | 735.00M | 766.00M | 750.00M |
Total operating expenses | 2.76B | 2.54B | 2.68B | 2.68B |
Operating income | 219.00M | 163.00M | 282.00M | 294.00M |
Other non operating income | 3.00M | -1.00M | 1.00M | -1.00M |
EBT including unusual items | -756.00M | -6.00M | 158.00M | 417.00M |
EBT excluding unusual items | 161.00M | 93.00M | 219.00M | 227.00M |
Income tax expense | 279.00M | 11.00M | 23.00M | 119.00M |
Effective tax rate | -36.90% | -183.33% | 14.56% | 28.54% |
Other operating expenses | -50.00M | -47.00M | -52.00M | -48.00M |
Net income | -1.13B | -15.00M | 126.00M | 294.00M |
Net profit margin | -37.93% | -0.56% | 4.26% | 9.88% |
Earnings per share | 0.44 | 0.36 | 0.56 | 0.58 |
Interest and investment income | 11.00M | 12.00M | 13.00M | 13.00M |
Interest expense | -69.00M | -78.00M | -77.00M | -74.00M |
Net interest expenses | -58.00M | -66.00M | -64.00M | -61.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 459.00M | 400.00M | 521.00M | 533.00M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events